Back to Method

Strategic Diagnosis

Strategic Diagnosis identifies the constraint, change, or contradiction that makes the current strategy insufficient.

What is actually making the current path stop working?

Why it exists.

Founders are often surrounded by accurate observations and still lack a diagnosis. Slower growth, channel conflict, product sprawl, and team friction may all be real without being the central problem.

A useful diagnosis names the force that explains the most important symptoms and identifies the decision that can change the system—not merely make the dashboard look better for a quarter.

From signal to consequential decision.

Diagnosis is a disciplined narrowing process: observe broadly, distinguish cause from symptom, locate the binding constraint, and state the decision it demands.

  1. 01

    Read the signals

    Collect changes, anomalies, friction, and evidence without forcing an early story.

  2. 02

    Separate symptom from cause

    Ask which explanation accounts for several signals at once.

  3. 03

    Locate the constraint

    Identify what most limits progress now—not what is merely imperfect.

  4. 04

    Name the decision

    Turn the diagnosis into a choice with a real trade-off and owner.

Questions for founders.

  1. 01

    Which facts would still matter if our preferred explanation were wrong?

  2. 02

    What appears to be a market problem but may be a position or product problem?

  3. 03

    What is the one constraint that makes several other problems persist?

  4. 04

    Which decision are we postponing by asking for more analysis?

When it is useful.

  • Growth has slowed and the organization is producing many competing explanations.
  • The company is adding initiatives faster than it is resolving trade-offs.
  • A global, product, organizational, or capital move would be expensive to reverse.

What it is not.

  • It is not a generic SWOT exercise or a catalog of everything that could improve.
  • It is not certainty disguised as analysis.
  • It does not replace primary research, operating data, or specialist diligence.